HUMAHumacyte, Inc.

Nasdaq humacyte.com


$ 4.01 $ -0.10 (-2.43 %)    

Monday, 29-Apr-2024 11:38:49 EDT
QQQ $ 432.29 $ -0.86 (-0.2 %)
DIA $ 383.04 $ -0.20 (-0.05 %)
SPY $ 509.73 $ -0.53 (-0.1 %)
TLT $ 88.74 $ 0.07 (0.08 %)
GLD $ 216.54 $ 0.47 (0.22 %)
$ 3.99
$ 4.11
$ 0.00 x 0
$ 4.03 x 100
$ 3.98 - $ 4.18
$ 1.96 - $ 5.60
689,524
na
412.65M
$ 1.49
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-24-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 03-29-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 02-16-2021 12-31-2020 10-K
14 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tommy-tuberville-trades-raise-eyebrows-again-senator-sells-put-options-buys-small-biotech-linked-to-ukraine-russia-war

Tommy Tuberville is one of the most active traders as a member of Congress. Here's a look at what he recently bought and sold.

 cantor-fitzgerald-reiterates-overweight-on-humacyte-maintains-7-price-target

Cantor Fitzgerald analyst Kristen Kluska reiterates Humacyte (NASDAQ:HUMA) with a Overweight and maintains $7 price target.

 piper-sandler-maintains-neutral-on-humacyte-maintains-4-price-target

Piper Sandler analyst Allison Bratzel maintains Humacyte (NASDAQ:HUMA) with a Neutral and maintains $4 price target.

 benchmark-reiterates-buy-on-humacyte-maintains-15-price-target

Benchmark analyst Bruce Jackson reiterates Humacyte (NASDAQ:HUMA) with a Buy and maintains $15 price target.

 earnings-scheduled-for-march-22-2024

Companies Reporting Before The Bell • Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share o...

 investor-optimism-improves-slightly-dow-jumps-over-250-points

The CNN Money Fear and Greed index showed a slight increase in the overall market sentiment on Thursday.

 earnings-preview-humacyte
Earnings Preview: Humacyte
03/21/2024 14:00:24

 senator-tommy-tubervilles-latest-2-stock-trades-attract-the-wrong-kind-of-attention-should-this-be-allowed

Stock trades made by Senator Tommy Tuberville are drawing scrutiny on social media with potential conflicts of interest.

 piper-sandler-maintains-neutral-on-humacyte-raises-price-target-to-4

Piper Sandler analyst Matt OBrien maintains Humacyte (NASDAQ:HUMA) with a Neutral and raises the price target from $3 to $4.

 why-zscaler-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

 why-humacyte-huma-shares-are-falling

Humacyte shares are trading lower by 29.2% during Friday's session. The company announced pricing of a $40.2 million public...

 why-netapp-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket

Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than...

 hewlett-packard-enterprise-posts-mixed-q1-results-joins-fisker-plug-power-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Friday.

 reported-earlier-humacyte-prices-402m-public-offering-of-134m-common-stock-at-3share

Humacyte intends to use the net proceeds that it will receive from the offering to continue the advancement of its pipeline in ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION